Navigation Links
Jazz Pharmaceuticals to Announce First Quarter 2010 Financial Results on May 5, 2010
Date:4/28/2010

PALO ALTO, Calif., April 28 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its first quarter 2010 financial results on Wednesday, May 5, 2010.  Jazz Pharmaceuticals will host an investor conference call and live webcast to give a company update, as well as to discuss financial results and guidance, on May 5, 2010, at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The live webcast and press release may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.  Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.  

Investors may participate in the conference call by dialing 1-866-356-3095 in the U.S., or 1-617-597-5391 outside the U.S., and entering passcode 32873868.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry.  For further information see

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014  Based on its recent analysis ... Frost & Sullivan recognizes Novian Health, Inc. with ... for Technology Innovation Leadership. Novian Health has greatly ... tumors with its proprietary technology, Novilase ® ... accurate, and easy-to-control ultrasound-guided thermo ablation device that ...
(Date:9/2/2014)... DIEGO , Sept. 2, 2014 ResMed (NYSE: ... and Astral™ 150 devices in the United ... generation of portable, lightweight, and user-friendly life support ventilators. ... offer unparalleled mobility and ease of use for patients ... and other adult and childhood respiratory disorders. The U.S. ...
(Date:9/2/2014)... BEDFORD, Mass. , Sept. 2, 2014  Hologic, Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the ... City , New York on ... Interested parties are invited to listen to the live ... Hologic,s website at www.hologic.com/investors-overview . An archive of the ...
Breaking Medicine Technology:Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3
... recognizes MedNet Solutions as the first QM Certified ... QualityMetric Incorporated announced today that MedNet Solutions, ... study management systems, is the first company to ... developed the QM Certified Scoring Partner program to ...
... Reports Significant Uptake of PlasmaBlade by U.S. Surgeons ... PEAK Surgical, Inc., a medical device company ... based on a proprietary technology, announced today several ... includes the PULSAR(R) Generator and the PEAK PlasmaBlade(TM) ...
Cached Medicine Technology:MedNet Solutions Certified to Score SF-12v2 Health Survey 2MedNet Solutions Certified to Score SF-12v2 Health Survey 3PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 2PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 3PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 4
(Date:9/2/2014)... (PRWEB) September 02, 2014 As an industry ... in an industry and predict change. Fortunately for him, that ... him to identify markets that are eager for change — ... of the hearing aid market indicated it was ripe for ... consumer,” Sapio explained. As a result, he took matters into ...
(Date:9/2/2014)... is available in Spanish . ... found, through an experiment conducted on rats, that hyperproteic diets ... use for groups with bone disease problems, such as the ... that vegetal proteinin the case of the present study, soy ... the former increased the level of calcium in bones by ...
(Date:9/2/2014)... nurses in their work care for patients who are ... shown that many nurses in training feel unprepared and ... during end-of-life care. , Scientists from the Sahlgrenska Academy ... Gothenburg, the University of Skvde and the Ersta Skndal ... caring for dying patients, their ideas about how to ...
(Date:9/2/2014)... September 02, 2014 Catalent, the ... development solutions for drugs, biologics and consumer health ... strategic partner, Eli Lilly’s growth, it is to ... at its Philadelphia Clinical Supply Center of Excellence. ... capabilities in its clinical supply facility in Schorndorf, ...
(Date:9/2/2014)... Splashtop Inc. , the worldwide ... NTT DoCoMo to deliver Splashtop Business Lite ... Lite is included in NTT DoCoMo’s “Business Plus” program. ... that empower users to remote access their corporate computers ... 18 million users worldwide. Splashtop delivers the best ...
Breaking Medicine News(10 mins):Health News:David Sapio Launches Zounds Hearing Franchise 2Health News:Study conducted on rats suggests that hyperproteic diets can be beneficial for bones 2Health News:Many nurses unprepared to meet dying patients 2Health News:Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions 2Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2
... affect heart despite symptom relief, experts say , , MONDAY, ... longer than they did 40 years ago, but not if ... the Mayo Clinic. , "When you look at persons with ... benefits over the last several decades of improved survival the ...
... for colorectal cancer screening, nearly two-thirds of screening colonoscopies ... in the October issue of the journal Gastroenterology, Thomas ... University School of Medicine and a Regenstrief Institute, Inc. ... who is at risk for colorectal cancer as well ...
... cancer who arent eligible for standard treatment is under ... unfortunate reality is that kidney problems often result from ... cisplatin and gemcitabine, says Dr. Teresa A. Coleman, hematologist-oncologist ... II study at about 120 sites in North America, ...
... Va., Oct. 29 CEL-SCI Corporation,(Amex: CVM ) ... of cancer immunotherapies on its new website. The link ... home page at http://www.cel-sci.com . Geert ... minds of many represents the future of cancer therapy. ...
... - Halogen Software Inc., the leading,provider of Web-based ... Vonage has selected Halogen eAppraisal with,Multi-Rater. Vonage, a ... a Web-based system to streamline the appraisal process ... top-notch services to its,customers. Vonage will be ...
... crisis in the developing world because of lack of ... His Royal Highness The Duke of York, Patron of ... , In the foreword to a special supplement ... The Duke of York says that this situation is ...
Cached Medicine News:Health News:Rheumatoid Arthritis Death Rate Unchanged 2Health News:Rheumatoid Arthritis Death Rate Unchanged 3Health News:1 size may not fit all 2Health News:New treatment option studied for bladder cancer 2Health News:New treatment option studied for bladder cancer 3Health News:Vonage Selects Halogen Software - New Solution to Streamline Employee Performance and Talent Management Across Organization 2Health News:British Royal highlights anesthesia crisis in the developing world 2
... magnifier is an easy to use, full ... so that the monitor (usually a ... magnifier and is not built in. This ... screen if desired in the future. Also ...
... Maxport is a powerful magnifier that helps the ... composed of a hand magnifier attached to a pair ... there is no need for a TV set. The ... magnify images on a book, a can of food, ...
... powerful, portable, hand-held digital magnifier designed for ... a computer mouse, Max connects directly to ... you to read newspapers, magazines, recipe cards ... any surface curved or straight. The optional ...
... Merlin is a superior full-color, auto-focus, ... vision user in mind, Merlin enables the ... black and white, high contrast positive or ... video magnifier, this optional feature enables the ...
Medicine Products: